Endometriosis and COVID-19: Clinical Presentation and Quality of Life, a Systematic Review
نویسندگان
1 Department of Molecular Medicine, University of Padua, Padua, Italy
2 USERN Office, Functional Neurosurgery Research Center, Shahid Beheshti University of Medical Sciences; Tehran, Iran
3 USERN Office, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5 School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
6 USERN Office, Shahid Beheshti University of Medical Sciences, Tehran, Iran
7 Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
8 Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran
doi
10.30699/jogcr.8.4.315چکیده
Background & Objective: Endometriosis, a common disease of the female reproductive system, could affect many aspects of women’s lives. Along with many other diseases, COVID-19 has affected the diagnostic or treatment approaches towards endometriosis. This systematic review aims to investigate COVID-19 in endometriosis patients in terms of prognosis, diagnosis, treatment, and quality of life during the pandemic.Materials & Methods: Relevant studies were identified through searching for endometriosis and COVID-19 in different databases, including PubMed, Medline, Scopus, and Web of Science, on 17 January 2022. Peer-reviewed published articles evaluating COVID-19 and endometriosis written in English were included.Results: Out of 115 articles, 9 manuscripts met our criteria. Endometriosis does not intensify the risk of COVID-19 infection. However, COVID-19 has changed the health care of endometriosis patients.Conclusion: COVID-19 has affected endometriosis patients’ life in many aspects, including their job, lifestyle, and health care. Further studies are recommended to evaluate how the pandemic has affected endometriosis patients.
